P-wave dispersion in systemic AA amyloidosis of familial Mediterranean fever
- PMID: 21484223
- DOI: 10.1007/s10067-011-1745-y
P-wave dispersion in systemic AA amyloidosis of familial Mediterranean fever
Abstract
Familial Mediterranean fever (FMF) is a hereditary disease characterized by attacks of fever and polyserositis. Recent studies differ as to whether FMF is associated with an abnormally high P-wave duration and P-wave dispersion, markers for supraventricular arrhythmogenicity. The aim of our study was to further evaluate atrial dispersion in FMF patients with amyloidosis. The study groups consisted of 16 patients with FMF and amyloidosis, and 16 age- and sex-matched control subjects. All participants underwent 12-lead electrocardiography under strict standards. P-wave length and P-wave dispersion in each individual patient were computed from a randomly selected beat and an averaged beat constructed from 7 to 12 beats, included in a 10-s electrocardiogram. No statistically significant differences were found between the groups for minimal, maximal, and average P-wave duration and P-wave dispersion, calculated either from a random beat or averaged beats. In conclusion, although a small difference cannot be excluded because of the small study groups, FMF patients with amyloidosis appear to have atrial conduction parameters similar to those of healthy controls, and therefore apparently do not have an increased electrocardiographic risk for developing supraventricular arrhythmias.
Similar articles
-
P wave dispersion in familial Mediterranean fever.Rheumatol Int. 2011 Dec;31(12):1591-4. doi: 10.1007/s00296-010-1508-0. Epub 2010 May 23. Rheumatol Int. 2011. PMID: 20496067
-
QT dispersion in amyloidosis due to familial Mediterranean fever.Rheumatol Int. 2012 Jul;32(7):1945-8. doi: 10.1007/s00296-011-1896-9. Epub 2011 Apr 2. Rheumatol Int. 2012. PMID: 21461715
-
P-wave duration and dispersion in children with uncomplicated familial Mediterranean fever.Mod Rheumatol. 2013 Nov;23(6):1166-71. doi: 10.1007/s10165-012-0815-6. Epub 2012 Dec 29. Mod Rheumatol. 2013. PMID: 23274952
-
Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever.Orphanet J Rare Dis. 2017 May 30;12(1):105. doi: 10.1186/s13023-017-0642-0. Orphanet J Rare Dis. 2017. PMID: 28558744 Free PMC article. Review.
-
[Familial Mediterranean Fever (FMF): from diagnosis to treatment].Sante. 2004 Oct-Dec;14(4):261-6. Sante. 2004. PMID: 15745878 Review. French.
Cited by
-
P wave dispersion and QT dispersion in adult Turkish migrants with familial mediterranean fever living in Germany.Int J Med Sci. 2014 Aug 21;11(11):1140-6. doi: 10.7150/ijms.9444. eCollection 2014. Int J Med Sci. 2014. PMID: 25170297 Free PMC article.
-
Cardiac repolarization abnormalities in children with familial Mediterranean fever.Pediatr Rheumatol Online J. 2022 May 23;20(1):38. doi: 10.1186/s12969-022-00696-5. Pediatr Rheumatol Online J. 2022. PMID: 35606812 Free PMC article.
-
Late ventricular potentials in familial Mediterranean fever with and without AA amyloidosis.Eur J Rheumatol. 2017 Sep;4(3):184-188. doi: 10.5152/eurjrheum.2017.16113. Epub 2017 Sep 1. Eur J Rheumatol. 2017. PMID: 29164000 Free PMC article.
-
Cardiovascular disease in patients with autoinflammatory syndromes.Rheumatol Int. 2018 Jan;38(1):37-50. doi: 10.1007/s00296-017-3854-7. Epub 2017 Nov 1. Rheumatol Int. 2018. PMID: 29094181 Review.
-
QT interval variability in familial Mediterranean fever: a study in colchicine-responsive and colchicine-resistant patients.Clin Rheumatol. 2012 May;31(5):795-9. doi: 10.1007/s10067-011-1926-8. Epub 2012 Jan 25. Clin Rheumatol. 2012. PMID: 22271228
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources